These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6171545)

  • 1. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Coker DD; Elias EG; Chretien PB; Gray WC; Coleman JJ; Zentai TA; Didolkar MS; Morris DM; Viravathana T; Hebel JR
    Head Neck Surg; 1981; 4(2):111-7. PubMed ID: 6171545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
    Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule.
    Vogl SE; Kaplan BH
    Cancer; 1979 Jul; 44(1):26-31. PubMed ID: 88256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE; Lerner H; Kaplan BH; Camacho F; Cinberg J; Schoenfeld D
    Cancer; 1982 Jul; 50(1):6-9. PubMed ID: 6177393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA; MacRae K; Hill BT
    Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
    Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
    Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
    Tannock I; Cummings B; Sorrenti V
    Cancer Treat Rep; 1982 Jun; 66(6):1421-4. PubMed ID: 6177413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarò P; Carlini P; Ruggeri EM; Ambesi Impiombato F; Del Vecchio MR; Giannarelli D; Perrino A
    Cancer; 1988 Jul; 62(2):251-61. PubMed ID: 2454721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer: phase II.
    Amer MH; Izbicki RM; Vaitkevicius VK; Al-Sarraf M
    Cancer; 1980 Jan; 45(2):217-23. PubMed ID: 6153149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
    Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
    Chiuten D; Vogl SE; Kaplan BH; Greenwald E
    Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of squamous cell cancer of the head and neck.
    Gill PG; Hains JD; Iyer P; Rozenbilds JG; Ahmad A; Abbott RL; David DJ; Ward GG; Brown MW; Harvey ND
    Med J Aust; 1983 May; 1(10):463-6. PubMed ID: 6188946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
    Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
    Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.